File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)

Conference Paper: FHL2 as a co-factor of XAF1 in the induction of apoptosis

TitleFHL2 as a co-factor of XAF1 in the induction of apoptosis
Authors
Issue Date2004
PublisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro
Citation
The 2004 Digestive Disease Week and the105th Annual Meeting of the American Gastroenterological Association (AGA), New Orleans, LA., 15-20 May 2004. In Gastroenterology, 2004, v. 126 n. 4 suppl. 2, p. A-132, abstract no. S938 How to Cite?
AbstractBACKGROUND AND AIMS: Previous studies have shown that XIAP-associated factor 1 (XAF1) plays an important role in resistance of cancer cells to apoptosis. The aim of this study is to further understand the molecular mechanisms by identifying XAFl-interacting proteins. METHODS: Yeast two-hybrid assay was used to identify Four and a Half of LIM-only protein 2 (FHL2) as an XAFl-interacting protein from an ovary cDNA library. The interaction was confirmed by co-immunoprecipitation and GST-protein pull down assays. The effects of FHL2 and XAF1 on cell viability and apoptosis were determined by transient transfection of the expression plamids into AGS gastnc cancer cells and SWill6 colon cancer cells. Transfected cells were exposed to 10-160 ng/ml of TRAIL (Tumor necrosis factor-Related Apoptosis-Inducing Ligand). Cell viability was determined by trypan blue exclusion assay or by MTT assay. Apoptosis rate was estimated by DAPI staining. RESULTS: We confirmed the specificity of the binding between XAF1 and FHL2 by direct in vitro binding test and co-immunoprecipitation assay from cell lysates. Ectopic over-expression of XAF1 or FHL2 alone did not significantly affect cell viability at 72h after serum withdrawal. However, co-expression of XAF1 and FHL2 resulted in a significant reduction of cell viability relative to control mock transfected ceils (reduced to 47% from 81% in AGS, p < 0.001; to 52% from 82% in SW1116, p < 0.001). After exposure to 80ng/ml of TRAIL, co-expression of XAF1 and FHL2 also significantly reduced cell viability by MTT assay as compared to control cells (44% vs 90% in AGS, p < 0.001; 59% vs 91% in SW1116, p < 0.001). In addition, they also increased cellular sensitivity to TRAIL-induced apoptosis as compared to control cells (40% vs 11% in AGS, p < 0.001; 28% vs 11% in SW1116, p= 0.001). CONCLUSIONS: We identified FHL2 as a novel XAFl-interacting protein and showed that FHL2 works together with XAF1 to induce cellular apoptosis.
Persistent Identifierhttp://hdl.handle.net/10722/103002
ISSN
2015 Impact Factor: 18.187
2015 SCImago Journal Rankings: 7.170

 

DC FieldValueLanguage
dc.contributor.authorYang, Y-
dc.contributor.authorLin, MC-
dc.contributor.authorChing, YP-
dc.contributor.authorLam, SK-
dc.contributor.authorXia, HHX-
dc.contributor.authorTu, S-
dc.contributor.authorZou, B-
dc.contributor.authorWang, J-
dc.contributor.authorLi, G-
dc.contributor.authorHe, H-
dc.contributor.authorGu, Q-
dc.contributor.authorPeng, J-
dc.contributor.authorKung, H-
dc.contributor.authorWong, BCY-
dc.date.accessioned2010-09-25T20:53:35Z-
dc.date.available2010-09-25T20:53:35Z-
dc.date.issued2004-
dc.identifier.citationThe 2004 Digestive Disease Week and the105th Annual Meeting of the American Gastroenterological Association (AGA), New Orleans, LA., 15-20 May 2004. In Gastroenterology, 2004, v. 126 n. 4 suppl. 2, p. A-132, abstract no. S938-
dc.identifier.issn0016-5085-
dc.identifier.urihttp://hdl.handle.net/10722/103002-
dc.description.abstractBACKGROUND AND AIMS: Previous studies have shown that XIAP-associated factor 1 (XAF1) plays an important role in resistance of cancer cells to apoptosis. The aim of this study is to further understand the molecular mechanisms by identifying XAFl-interacting proteins. METHODS: Yeast two-hybrid assay was used to identify Four and a Half of LIM-only protein 2 (FHL2) as an XAFl-interacting protein from an ovary cDNA library. The interaction was confirmed by co-immunoprecipitation and GST-protein pull down assays. The effects of FHL2 and XAF1 on cell viability and apoptosis were determined by transient transfection of the expression plamids into AGS gastnc cancer cells and SWill6 colon cancer cells. Transfected cells were exposed to 10-160 ng/ml of TRAIL (Tumor necrosis factor-Related Apoptosis-Inducing Ligand). Cell viability was determined by trypan blue exclusion assay or by MTT assay. Apoptosis rate was estimated by DAPI staining. RESULTS: We confirmed the specificity of the binding between XAF1 and FHL2 by direct in vitro binding test and co-immunoprecipitation assay from cell lysates. Ectopic over-expression of XAF1 or FHL2 alone did not significantly affect cell viability at 72h after serum withdrawal. However, co-expression of XAF1 and FHL2 resulted in a significant reduction of cell viability relative to control mock transfected ceils (reduced to 47% from 81% in AGS, p < 0.001; to 52% from 82% in SW1116, p < 0.001). After exposure to 80ng/ml of TRAIL, co-expression of XAF1 and FHL2 also significantly reduced cell viability by MTT assay as compared to control cells (44% vs 90% in AGS, p < 0.001; 59% vs 91% in SW1116, p < 0.001). In addition, they also increased cellular sensitivity to TRAIL-induced apoptosis as compared to control cells (40% vs 11% in AGS, p < 0.001; 28% vs 11% in SW1116, p= 0.001). CONCLUSIONS: We identified FHL2 as a novel XAFl-interacting protein and showed that FHL2 works together with XAF1 to induce cellular apoptosis.-
dc.languageeng-
dc.publisherWB Saunders Co. The Journal's web site is located at http://www.elsevier.com/locate/gastro-
dc.relation.ispartofGastroenterology-
dc.titleFHL2 as a co-factor of XAF1 in the induction of apoptosis-
dc.typeConference_Paper-
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0016-5085&volume=126 &issue=4 Suppl 2&spage=S938&epage=&date=2004&atitle=FHL2+As+a+Co-Factor+of+XAF1+in+the+Induction+of+Apoptosisen_HK
dc.identifier.emailLin, MC: mcllin@hku.hk-
dc.identifier.emailChing, YP: ypching@hku.hk-
dc.identifier.emailLam, SK: hrmelsk@hkucc.hku.hk-
dc.identifier.emailXia, HHX: hhxxia@hku.hk-
dc.identifier.emailZou, B: zoubing@hkucc.hku.hk-
dc.identifier.emailHe, H: cecily_bb3@hotmail.com-
dc.identifier.emailGu, Q: qgua@hkucc.hku.hk-
dc.identifier.emailKung, H: hkung@hkucc.hku.hk-
dc.identifier.emailWong, BCY: bcywong@hku.hk-
dc.identifier.authorityLin, MC=rp00746-
dc.identifier.authorityChing, YP=rp00469-
dc.identifier.authorityWong, BCY=rp00429-
dc.identifier.doi10.1016/S0016-5085(04)80008-8-
dc.identifier.hkuros86062-
dc.identifier.volume126-
dc.identifier.issue4 suppl. 2-
dc.identifier.spageA-132, abstract no. S938-
dc.identifier.epageA-132, abstract no. S938-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats